Biosimilars and Patients: Addressing Safety, Cost, Anxiety
Physicians can respond to pushback from patients on switching to a biosimilar by offering resources and discussing options for both biosimilar and reference drugs.
New York United States University Of Rochester Medical Center Sameer Awsare Vivek Kaul Kaiser Permanente
Source: medscape.com